Joint Webinar: TERMIS, ISCT and AST

ABOUT THE WEBINAR

TERMIS, ISCT, and AST recognize their shared objectives and have joined forces to host a quarterly webinar series. These sessions aim to advance knowledge and drive progress in organ bioengineering, uniting the community around a common vision: enabling regenerative medicine to provide future solutions for organ transplantation. 

As such, TERMIS, ISCT and AST host their next member-exclusive joint webinar, to tackle Stem Cell and EV Therapies, and Advanced Cell Therapies for Severe Disease Conditions. 

Webinar speakers include Renato Romagnoli, MD, PhD, presenting “Stem Cell and EV Therapies During Ex-Situ Liver Perfusion,” and ISCT member Camillo Ricordi, PhD, presenting “From Advanced Cell Therapies for Severe Disease Conditions to Prevention and Reversal of Disease Progression to Improve Healthspan.”

Tune in for a chance to listen and engage with these experts!

 WEBINAR SPEAKERS

Camillo Ricordi, MD
 Professor of Surgery, Medicine, Microbiology and Immunology
University of Miami Miller School of Medicine
United States

Camillo Ricordi, MD, is a Professor of Surgery, Medicine, Biomedical Engineering, Microbiology and Immunology at the University of Miami, where he serves also as Chief of the Division of Cellular Transplantation, Department of Surgery, Director of the Cell Transplant Center and Director Emeritus of the Diabetes Research Institute (DRI). Acknowledged by his peers as one of the world's leading scientists in diabetes cure-focused research, cell transplantation and regenerative medicine, Ricordi is well-known for inventing the technology that made it possible to isolate large numbers of islet cells (insulin-producing cells) from the human pancreas. He was eventually recruited at the University of Pittsburgh Transplant Institute, where he led the team that performed the first series of successful clinical islet allotransplants to reverse diabetes. The procedure is now used by centers performing clinical islet transplants worldwide.  In addition to diabetes cure-focused research, Ricordi’s interests include Healthspan Medicine and regenerative biotherapeutic strategies, to prevent or treat chronic degenerative disease conditions, and to prolong healthy lifespan (Healthspan). Ricordi received over 100 honors and international awards. He  contributed 1,250 publications, that received over 62,000 citations (120 H-index) and he was awarded 28 patents. In 2023 he published “THE HEALTHSPAN CODE” and in 2025 “THERAPEUTIC REVOLUTION."

Renato Romagnoli, MD, PhD
 Associate Professor and Director
University of Turin School of Medicine
University Hospital Città della Salute e della Scienza di Torino
Italy

Renato Romagnoli, MD, PhD graduated summa cum laude in Medicine and Surgery from the University of Turin in 1990 and completed his specialization in General Surgery in 1995. He has served as a Staff Surgeon in the Turin Liver Transplant Center since 1998 and currently directs the General Surgery and Transplant Department of the University Hospital “Città della Salute e della Scienza di Torino.” A regional leader in transplant programs and Coordinator of Transplant Activities for the Piedmont Region, he has authored over 250 scientific publications and advances research in liver stem cell therapies and ex situ liver machine perfusion technologies.